Rare Diseases market is projected to grow at a CAGR of 8.8% by 2034: Visiongain [Yahoo! Finance]
Benitec Biopharma Inc. (BNTC)
US:NASDAQ Investor Relations:
benitec.com/for-investors/investor-faqs
Company Research
Source: Yahoo! Finance
Conditions, Hematologic Disorders, Infectious Diseases, Musculoskeletal Disorders, Cardiovascular Disorders, Others), by Type (Non Biologics, Biologics), by End-users (Specialty Pharmacies, Hospital Pharmacies, Retail Pharmacies), by Age Group (Adult, Paediatric) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies The global rare diseases market is estimated at US$204.67 billion in 2024 and is projected to grow at a CAGR of 8.8% during the forecast period 2024-2034. Increasing Demand from Emerging Economies The burgeoning demand for rare disease treatments from emerging economies presents a pivotal opportunity for growth within the rare diseases market. As healthcare infrastructure in these regions continues to improve and access to medical care expands, there is a corresponding increase in the diagnosis and treatment of rare diseases. This rising demand is fuelled by several factors, including greater awareness among healthcare professionals and
Show less
Read more
Impact Snapshot
Event Time:
BNTC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BNTC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BNTC alerts
High impacting Benitec Biopharma Inc. news events
Weekly update
A roundup of the hottest topics
BNTC
News
- Benitec Biopharma Inc. (NASDAQ: BNTC) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $30.00 price target on the stock.MarketBeat
- Gene Therapy R&D market is projected to grow at a CAGR of 29.8% by 2034: Visiongain [Yahoo! Finance]Yahoo! Finance
- Benitec Biopharma Releases Third Quarter 2024 Financial Results and Provides Operational Update [Yahoo! Finance]Yahoo! Finance
- Benitec Biopharma Releases Third Quarter 2024 Financial Results and Provides Operational UpdateGlobeNewswire
- Benitec Biopharma to Participate in the Citizens JMP Life Science Conference [Yahoo! Finance]Yahoo! Finance
BNTC
Sec Filings
- 5/29/24 - Form 424B3
- 5/29/24 - Form EFFECT
- 5/16/24 - Form S-1
- BNTC's page on the SEC website